These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8571298)

  • 21. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pigmented purpuric contact dermatitis from Disperse Blue 106 and 124 dyes.
    Komericki P; Aberer W; Arbab E; Kovacevic Z; Kränke B
    J Am Acad Dermatol; 2001 Sep; 45(3):456-8. PubMed ID: 11511847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adverse events of generic drugs in the elderly].
    Adam M; Coffinet C; Corbière C; Berthe A; Beauruelle C; Doucet J
    Therapie; 2011; 66(5):459-60. PubMed ID: 22031691
    [No Abstract]   [Full Text] [Related]  

  • 25. Type IV hypersensitivity to vitamin K.
    Sommer S; Wilkinson SM; Peckham D; Wilson C
    Contact Dermatitis; 2002 Feb; 46(2):94-6. PubMed ID: 11918602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed Allergic Reaction to Acenocoumarol With a Positive Lymphocyte Transformation Test.
    Dominguez-Ortega J; Entrala A; Pola-Bibian B; Gonzalez-Muñoz M; Fiandor A; Quirce S
    J Investig Allergol Clin Immunol; 2016; 26(4):273-4. PubMed ID: 27470649
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute hemorrhage due anti-vitamin K agents. A prognostic and descriptive study].
    Ben Ameur Y; Chaabane O; Zairi I; Longo S; Battikh K; Slimane ML
    Tunis Med; 2009 Nov; 87(11):763-9. PubMed ID: 20209835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory effects in vitro of vitamin K antagonist acenocoumarol.
    Schroecksnadel S; Gostner J; Jenny M; Kurz K; Schennach H; Weiss G; Fuchs D
    Thromb Res; 2013 Jun; 131(6):e264-9. PubMed ID: 23481478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?].
    Jończyk-Skórka K; Śliwczyńska-Rodziewicz D; Jarmak A; Kowalski J
    Pol Merkur Lekarski; 2015 Mar; 38(225):144-9. PubMed ID: 25815614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sintrom-induced cutaneous necrosis; a little-known complication].
    Núñez L; Córcoles JL; Romero A; Guedes P; Amorós C; Morillas P
    Arch Cardiol Mex; 2018; 88(1):76-77. PubMed ID: 28864238
    [No Abstract]   [Full Text] [Related]  

  • 31. [Necrotic leg ulcers induced by vitamin K antagonists: five cases].
    Bezier M; Perceau G; Reguiai Z; Remy-Leroux V; Tchen T; Durlach A; Grange F; Nguyen P; Bernard P
    Ann Dermatol Venereol; 2011 Oct; 138(10):657-63. PubMed ID: 21978501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Uncommon complication of vitamin K antagonists: hemobilia].
    Laloux S; Mallet L; Lefrere JJ; Languille M; Dubertret M; Petite JP
    Presse Med; 1986 Sep; 15(30):1423-4. PubMed ID: 2947066
    [No Abstract]   [Full Text] [Related]  

  • 33. Occupational contact dermatitis to textile dyes in airline personnel.
    Khanna M; Sasseville D
    Am J Contact Dermat; 2001 Dec; 12(4):208-10. PubMed ID: 11753894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
    ; Bousser MG; Bouthier J; Büller HR; Cohen AT; Crijns H; Davidson BL; Halperin J; Hankey G; Levy S; Pengo V; Prandoni P; Prins MH; Tomkowski W; Torp-Pedersen C; Wyse DG
    Lancet; 2008 Jan; 371(9609):315-21. PubMed ID: 18294998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anticoagulants. Antivitamins K: principles and rules of use, posology].
    Mismetti P; Decousus H
    Rev Prat; 1995 Apr; 45(8):1014-7. PubMed ID: 7761767
    [No Abstract]   [Full Text] [Related]  

  • 37. "Extra-edge effect": a further problem in patch test diagnosis?
    Corazza M; Osti F; Mantovani L; Virgili A
    Acta Derm Venereol; 2008; 88(2):198-9. PubMed ID: 18311466
    [No Abstract]   [Full Text] [Related]  

  • 38. [Quantification of the part allocated to the preventability of vitamin K antagonists therapy bleeding events].
    Gras-Champel V; Brenet-Dufour V; Moragny J; Masson H; Davidau E; Masmoudi K; Andrejak M
    Therapie; 2010; 65(3):261-8. PubMed ID: 20699080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmaceutical counselling and evaluation of the knowledge of hospitalized patients treated with anti-vitamin K drugs].
    Labrosse H; Vantard N; Garcia K; Leboucher G; Charpiat B
    Ann Pharm Fr; 2006 Sep; 64(5):344-9. PubMed ID: 17095954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.